Williamsville, NY, United States of America

Yau-Kwan Ho

This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yau-Kwan Ho. Retrieved from https://idiyas.com/inventor/yau-kwan-ho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yau-Kwan Ho: Innovator in Polynucleotide Research

Introduction

Yau-Kwan Ho is a notable inventor based in Williamsville, NY (US). He has made significant contributions to the field of molecular biology, particularly in the development of novel polynucleotide analogs. His work has implications for cancer treatment and therapeutic applications.

Latest Patents

Yau-Kwan Ho holds a patent for "Novel polynucleotide analogs, methods for inhibiting nucleic acid." This patent describes polyribonucleotide analogs that are partially substituted by the introduction of mercapto groups and fluorine at the 5-position of some of their cytosine and uracil bases. These analogs exhibit effective in vivo antitumor activity. The double-stranded complexes formed from such polynucleotides are especially active as interferon inducers. He has 1 patent to his name.

Career Highlights

Yau-Kwan Ho is affiliated with the State University of New York, where he conducts research and contributes to academic advancements in his field. His work has garnered attention for its innovative approach to addressing complex biological challenges.

Collaborations

He has collaborated with esteemed colleagues, including Thomas J Bardos and Steven J Kasper, to further enhance the impact of his research.

Conclusion

Yau-Kwan Ho's contributions to the field of polynucleotide research highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to pave the way for new therapeutic strategies in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…